Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma

por Ge, Zhouhong, Helmijr, Jean C.A., Jansen, Maurice P.H.M., Boor, Patrick P.C., Noordam, Lisanne, Peppelenbosch, Maikel, Kwekkeboom, Jaap, Kraan, Jaco, Sprengers, Dave
Publicado 2021

Application of circulating tumor DNA in prospective clinical oncology trials – standardization of preanalytical conditions

por van Dessel, Lisanne F., Beije, Nick, Helmijr, Jean C.A., Vitale, Silvia R., Kraan, Jaco, Look, Maxime P., de Wit, Ronald, Sleijfer, Stefan, Jansen, Maurice P.H.M., Martens, John W.M., Lolkema, Martijn P.
Publicado 2017

Liquid biopsy in esophageal cancer: a case report of false-positive circulating tumor DNA detection due to clonal hematopoiesis

por Spoor, Jonathan, Eyck, Ben M., Atmodimedjo, Peggy N., Jansen, Maurice P. H. M., Helmijr, Jean C. A., Martens, John W. M., van der Wilk, Berend J., van Lanschot, J. Jan B., Dinjens, Winand N. M.
Publicado 2021

High‐throughput isolation of circulating tumor DNA: a comparison of automated platforms

por van Dessel, Lisanne F., Vitale, Silvia R., Helmijr, Jean C. A., Wilting, Saskia M., van der Vlugt‐Daane, Michelle, Oomen‐de Hoop, Esther, Sleijfer, Stefan, Martens, John W. M., Jansen, Maurice P. H. M., Lolkema, Martijn P.
Publicado 2018

Somatic Tumor Mutations Detected by Targeted Next Generation Sequencing in Minute Amounts of Serum-Derived Cell-Free DNA

por Weerts, Marjolein J. A., van Marion, Ronald, Helmijr, Jean C. A., Beaufort, Corine M., Krol, Niels M. G., Trapman-Jansen, Anita M. A. C., Dinjens, Winand N. M., Sleijfer, Stefan, Jansen, Maurice P. H. M., Martens, John W. M.
Publicado 2017

Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes

por Beaufort, Corine M., Helmijr, Jean C. A., Piskorz, Anna M., Hoogstraat, Marlous, Ruigrok-Ritstier, Kirsten, Besselink, Nicolle, Murtaza, Muhammed, van IJcken, Wilfred F. J., Heine, Anouk A. J., Smid, Marcel, Koudijs, Marco J., Brenton, James D., Berns, Els M. J. J., Helleman, Jozien
Publicado 2014

TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer

por Vitale, Silvia R., Groenendijk, Floris H., van Marion, Ronald, Beaufort, Corine M., Helmijr, Jean C., Jan Dubbink, Hendrikus, N. M. Dinjens, Winand, Ewing-Graham, Patricia C., Smolders, Ramon, van Doorn, Helena C., Boere, Ingrid A., Berns, Els M. J. J., Helleman, Jozien, Jansen, Maurice P. H. M.
Publicado 2020

Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patients

por Valle-Inclan, Jose Espejo, Stangl, Christina, de Jong, Anouk C., van Dessel, Lisanne F., van Roosmalen, Markus J., Helmijr, Jean C. A., Renkens, Ivo, Janssen, Roel, de Blank, Sam, de Witte, Chris J., Martens, John W. M., Jansen, Maurice P. H. M., Lolkema, Martijn P., Kloosterman, Wigard P.
Publicado 2021

Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen

por Jansen, Maurice P.H.M., Martens, John W.M., Helmijr, Jean C.A., Beaufort, Corine M., van Marion, Ronald, Krol, Niels M.G., Monkhorst, Kim, Trapman-Jansen, Anita M.A.C., Meijer-van Gelder, Marion E., Weerts, Marjolein J.A., Ramirez-Ardila, Diana E., Jan Dubbink, Hendrikus, Foekens, John A., Sleijfer, Stefan, Berns, Els M.J.J.
Publicado 2016